Our Vision and Mission
For too long, people have lived with the fear and uncertainty of a cancer diagnosis, creating a sense of helplessness and hopelessness. We at Unum know that the only course of action, the only way to eliminate the fear and uncertainty of cancer is to improve the treatment paradigm. Our team comes to work each day driven by that opportunity and a sense of urgency to deliver novel cell therapies to not only treat but cure cancer and provide new hope to patients and their families.
Advancements in cancer therapies are helping to prolong the lives of patients, yet many cancers, especially solid tumors, remain out of reach. Unum’s new platform technologies, Bolt-On Chimeric Receptor (BOXR) and Antibody-Coupled T Cell Receptor (ACTR), engineer a patient’s own T cells to:
- Overcome immunosuppression in the solid tumor microenvironment that would otherwise prevent T cells from functioning
- Selectively target tumor antigens while preventing attacks on healthy cells